Lenalidomide Exposure Prior to Autologous Stem Cell Transplantation May Increase Risk of Venous Thromboembolism (VTE) in Patients with Multiple Myeloma (MM)

Christopher Robert DAngelo; Natalie S. Callander

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Lenalidomide Exposure Prior to Autologous Stem Cell Transplantation May Increase Risk of Venous Thromboembolism (VTE) in Patients with Multiple Myeloma (MM)

【24h】

Lenalidomide Exposure Prior to Autologous Stem Cell Transplantation May Increase Risk of Venous Thromboembolism (VTE) in Patients with Multiple Myeloma (MM)

机译：在自体干细胞移植之前的Lenalidomide暴露可能会增加多发性骨髓瘤患者静脉血栓栓塞（VTE）的风险（mm）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2018年第3期|共1页
作者
Christopher Robert DAngelo; Natalie S. Callander;
展开▼
作者单位

University of Wisconsin;

Bone Marrow Transplant Program Carbone Cancer Center University of Wisconsin—Madison;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Lenalidomide Exposure Prior to Autologous Stem Cell Transplantation May Increase Risk of Venous Thromboembolism (VTE) in Patients with Multiple Myeloma (MM) [J] . Christopher Robert DAngelo, Natalie S. Callander Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：在自体干细胞移植之前的Lenalidomide暴露可能会增加多发性骨髓瘤患者静脉血栓栓塞（VTE）的风险（mm）
2. Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma [J] . Marc-Andrea Baertsch, Jana Schlenzka, Elias K. Mai, BMC Cancer . 2016,第1期

机译：德语德语骨髓瘤多中心小组（GMMG）试验ReLApsE的原理和设计：来那度胺/地塞米松与来那度胺/地塞米松联合随后自体干细胞移植和来那度胺维持治疗多发性骨髓瘤患者的随机，开放，多中心III期试验
3. Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT) [J] . Brian G. M. Durie, Antje Hoering, Rachael Sexton, Blood cancer journal. . 2020,第5期

机译：随机阶段III试验SO0777的长期随访S0777：硼替佐米，Lenalalomide和地塞米松对患者（PTS）与先前未经治疗的多发性骨髓瘤的患者（PTS），没有目的自身的干细胞移植（ASCT）
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. A review of the management of patients at risk for or diagnosed with venous thromboembolism (VTE) at an academic medical center; and the cost-effectiveness of diagnostic strategies for VTE [D] . Lee, Jung-Ah 2008

机译：在学术医学中心对有风险或被诊断患有静脉血栓栓塞（VTE）的患者的管理进行审查；和VTE诊断策略的成本效益
6. Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized open multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma [O] . Marc-Andrea Baertsch, Jana Schlenzka, Elias K. Mai, 2016

机译：德语德语骨髓瘤多中心小组（GMMG）试验ReLApsE的原理和设计：来那度胺/地塞米松与来那度胺/地塞米松联合随后自体干细胞移植和来那度胺维持治疗多发性骨髓瘤的患者的随机开放多中心III期试验
7. Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma [O] . Bärtsch, Marc-Andrea, Schlenzka, Jana, Mai, Elias K., 2017

机译：德语系骨髓瘤多中心小组（RelepsE）试验的原理和设计：来那度胺/地塞米松与来那度胺/地塞米松联合随后的自体干细胞移植和来那度胺维持治疗多发性骨髓瘤的患者的随机，开放，多中心III期试验

Lenalidomide Exposure Prior to Autologous Stem Cell Transplantation May Increase Risk of Venous Thromboembolism (VTE) in Patients with Multiple Myeloma (MM)

著录项

引文网络

相似文献

相关主题

期刊订阅